Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2019

Feb 19, 2019

30016_dirs_2019-02-19_495d22f1-b3b2-4c18-8ab8-74e817412511.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2019-02-14

Reporting Person: MAZELSKY JAY (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-14 Common Stock M 403 Acquired 21802 Direct
2019-02-14 Common Stock M 471 Acquired 22273 Direct
2019-02-14 Common Stock M 737 Acquired 23010 Direct
2019-02-14 Common Stock M 459 Acquired 23469 Direct
2019-02-14 Common Stock M 505 Acquired 23974 Direct
2019-02-14 Common Stock F 762 $206.94 Disposed 23212 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-14 Non-Qualified Stock Option (right-to-buy) $206.94 M 20753 Acquired 2029-02-13 Common Stock (20753) Direct
2019-02-14 Incentive Stock Option (right-to-buy) $206.94 M 483 Acquired 2029-02-13 Common Stock (483) Direct
2019-02-14 Restricted Stock Unit $ M 2175 Acquired Common Stock (2175) Direct
2019-02-14 Restricted Stock Unit $ M 403 Disposed Common Stock (403) Direct
2019-02-14 Restricted Stock Unit $ M 471 Disposed Common Stock (471) Direct
2019-02-14 Restricted Stock Unit $ M 737 Disposed Common Stock (737) Direct
2019-02-14 Restricted Stock Unit $ M 459 Disposed Common Stock (459) Direct
2019-02-14 Restricted Stock Unit $ M 505 Disposed Common Stock (505) Direct

Footnotes

F1: Includes 25 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on December 31, 2018.

F2: 2. Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2020.

F3: Grant of option to buy shares of Issuer common stock that becomes exercisable on the fifth anniversary of the date of grant.

F4: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

F5: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2015. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split").

F6: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split.

F7: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2017.

F8: 7. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.

F9: 7. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.

F10: Not applicable.